… PI-RADS™ v2 is not a comprehensive prostate cancer … of suspected recurrent prostate
cancer following therapy, … ) that may be involved with prostate cancer. Furthermore, it does not …

… that PI-RADS v2 is a reliable and replicable reporting system for the assessment of prostate
cancer. … v2 has shown better diagnostic performance to rule out prostate cancer. Less false …

… prostate cancer with synonyms for magnetic resonance imaging and synonyms for PI-RADS
or … We included studies since 2012 if (1) the PI-RADS classification in reporting prostate MRI …

… of PI-RADS category 3 lesions that were negative for (clinically significant) prostate
cancer on … This review focuses on indeterminate lesions on prostate MRI (assigned as PI-RADS …

… high performance of PI-RADS V2 for the detection of GS ≥7 prostate cancer by using MR …
Outcomes from existing PI-RADS V2 decision rules for determining the overall PI-RADS …

… introduced a new pathological scoring system for prostate cancer. Our goal was to prospectively
evaluate the cancer detection rates for each PI-RADS, version 2 category and compare …

… Prostate cancer is the second most prevalent cancer in men worldwide and its incidence
is expected to double by 2030. Multi-parametric magnetic resonance imaging (MRI) …

… The probability of clinically significant prostate cancer according to the PI-RADS score
was defined as follows: score 1, very low (clinically significant cancer is highly unlikely to be …

… high-grade prostate cancer detection rate with PI-RADS. PPV … prostate cancer with PI-RADS.
The outcome for statistical analyses was the detection of clinically significant prostate cancer…

… clinically significant prostate cancer at a particular location. PI-RADS assessment categories
range from 1 to 5 with 5 being most likely to represent clinically significant prostate cancer. …